Should You Buy Canopy Growth Stock on the Rebound?

Axe Cap view

Be Careful With Canopy Growth Despite a Promising Bounce

Canopy Growth’s recent numbers improve but the structural risks keep it a wait-and-watch stock.

Canopy Growth showed a solid step forward with 13% revenue growth and a much smaller loss in its recent quarter. For a company in the cannabis space—often a minefield of hype and headline risk—this is encouraging. Yet it remains a volatile penny stock, heavily diluted by over 400% in the last three years. That share dilution matters a lot: it means your stake today might be far less valuable down the line if the company needs more capital. South African investors watching USD/ZAR should remember that Canopy’s turnaround story is far from guaranteed, making currency moves secondary to company fundamentals here. For those with exposure through global tech-heavy funds or ETFs, tune in but don’t jump in. If you’re looking at the South African market, there’s little direct play on cannabis yet, so patience and a keen eye on the FX moves remain key. this is just our opinion and not financial advice